Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis

Abstract Objective Sporadic fatal adverse events have been reported during treatment of multiple sclerosis with alemtuzumab. To provide a systematic overview, we searched the centralized European Medicines Agency database of suspected adverse reactions related to medicinal products (EudraVigilance)...

Full description

Bibliographic Details
Published in:BMC Research Notes
Main Authors: Trygve Holmøy, Børre Fevang, David Benee Olsen, Olav Spigset, Lars Bø
Format: Article
Language:English
Published: BMC 2019-08-01
Subjects:
Multiple sclerosis
Treatment
Alemtuzumab
Adverse event
Online Access:http://link.springer.com/article/10.1186/s13104-019-4507-6

Internet

http://link.springer.com/article/10.1186/s13104-019-4507-6

Similar Items